Energy-Dependent Nucleolar Localization of P53 in Vitro Requires Two Discrete Regions Within the P53 Carboxyl Terminus

Total Page:16

File Type:pdf, Size:1020Kb

Energy-Dependent Nucleolar Localization of P53 in Vitro Requires Two Discrete Regions Within the P53 Carboxyl Terminus Oncogene (2007) 26, 3878–3891 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc ORIGINAL ARTICLE Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus O Karni-Schmidt1, A Friedler2,3, A Zupnick1, K McKinney1, M Mattia1, R Beckerman1, P Bouvet4, M Sheetz1, A Fersht2 and C Prives1 1Department of Biological Sciences, Columbia University, New York, USA; 2Department of MRC-CPE, Center for Protein Engineering, Medical Research Council, Cambridge, UK; 3Department of Organic Chemistry, The Hebrew University of Jerusalem, Givat Ram, Jerusalem, Israel; 4Laboratoire de Biologie Mole´culaire de la Cellule/UMR 5161, Ecole Normale Supe´rieure de Lyon 46, Alle´e d’Italie 69364 Lyon Cedex, France The p53 tumor suppressor is a nucleocytoplasmic shuttling concentration, is presumably inactive as a transcription protein that is found predominantly in the nucleus of cells. factor and is diffusely distributed throughout the cell. In In addition to mutation, abnormal p53 cellular localiza- response to DNA damage or other forms of cellular tion is one of the mechanisms that inactivate p53 function. stress, p53 protein accumulates, frequently becomes To further understand features of p53 that contribute to extensively post-translationally modified and concen- the regulation of its trafficking within the cell, we analysed trates within the nucleus (Giaccia and Kastan, 1998; the subnuclear localization of wild-type and mutant p53 in Appella and Anderson, 2001; Liang and Clarke, 2001; human cells that were either permeabilized with detergent Prives and Manley, 2001). or treated with the proteasome inhibitor MG132. We, One property of the nucleus, analogous to cytoplas- here, showthat either endogenously expressed or exoge- mic organelles, is the existence of subnuclear domains. nously added p53 protein localizes to the nucleolus in These nuclear compartments concentrate specific sets detergent-permeabilized cells in a concentration- and ATP of functionally related proteins. Within the nucleus, hydrolysis-dependent manner. Two discrete regions within the nucleolus is the site of ribosomal RNA (rRNA) the carboxyl terminus of p53 are essential for nucleolar transcription, modification, maturation and ribosomal localization in permeabilized cells. Similarly, localization assembly (Carmo-Fonseca et al., 2000; Olson et al., of p53 to the nucleolus after proteasome inhibition in 2000; Leung et al., 2003). Although easily visualized unpermeabilized cells requires sequences within the as a discrete subnuclear entity, the nucleolus is not carboxyl terminus of p53. Interestingly, genotoxic stress separated from the surrounding nucleoplasm by markedly decreases the association of p53 with the membranes, and thus proteins localize to nucleoli by nucleolus, and phosphorylation of p53 at S392, a site processes that do not involve active membrane trans- that is modified by such stress, partially impairs its port. In recent years, multiple proteins involved in nucleolar localization. The possible significance of these cell-cycle progression were identified, whose regulation findings is discussed. involves sequestration within the nucleolus. In response Oncogene (2007) 26, 3878–3891. doi:10.1038/sj.onc.1210162; to oncogenic stress, the p14ARF protein may inactivate published online 22 January 2007 the mouse double minute (MDM)2 oncoprotein (an inhibitor of p53) by inducing nucleolar sequestration Keywords: p53; nucleolus; DNA damage; NoLS of MDM2 (Zhang et al., 1998; Tao and Levine, 1999; Weber et al., 1999; Ashcroft et al., 2000). The requirement of MDM2 localization to nucleoli for its inactivation by p14ARF, however, is not obliga- tory (Llanos et al., 2001). Among other cell cycle Introduction regulators and checkpoint factors that associate with the nucleolus are the Werner’s Syndrome Helicase (Marci- The human p53 protein contains 393 amino acids and is niak et al., 1998), the telomere maintenance enzyme comprised of several functional domains (Prives and (hTERT) (Wong et al., 2002) and Cdc14, a protein Hall, 1999). Appropriate subcellular localization is phosphatase in yeast crucial for promoting exit from crucial for regulating p53 function. Under unstressed mitosis Visintin et al., 1998). These and other findings conditions, the p53 protein is generally present at a low imply a novel role for the nucleolus’s participation in the regulation of cell cycle proteins (as reviewed in Visintin and Amon, 2000; Lamond and Sleeman, 2003; Leung Correspondence: Dr C Prives, Department of Biological Sciences, and Lamond, 2003; Mayer and Grummt, 2005; Olson Columbia University, 816 Fairchild, NY 10027 USA. E-mail: [email protected] and Dundr, 2005). Received 18 July 2006; revised 22 September 2006; accepted 23 October Within the nucleus, p53 has been reported to be 2006; published online 22 January 2007 associated with at least three subnuclear compartments ATP-dependent p53 nucleolar localization O Karni-Schmidt et al 3879 including the nucleolus, promyelocytic leukemia bodies loss of p53 upon permeabilization may reflect the release and cajal bodies (Mogaki et al., 1993; Benninghoff et al., of a subpopulation of p53 that is not bound to nuclear 1999; Rubbi and Milner, 2000; Horky et al., 2001; structures. Klibanov et al., 2001; Wesierska-Gadek et al., 2002; Parallel cultures to those in Figure 1a were either Young et al., 2002; Zimber et al., 2004). Approximately directly fixed with 4% paraformaldehyde (unpermeabi- half of nuclear p53 is soluble, whereas the remainder lized) or first permeabilized with PBS/1% Triton X-100 associates with nuclear structures (Zerrahn et al., 1992). for 2 min before fixation. Cells were then incubated p53 can interact with a number of nucleolar components with anti-p53 antibodies followed by incubation with such as L5 ribosomal protein (Marechal et al., 1994), secondary antibodies and analysis by laser scanning topoisomerase I (Gobert et al., 1996), nucleolin (Daniely microscopy and differential interference contrast (DIC). et al., 2002), nucleophosmin (Colombo et al., 2002) and As expected, without permeabilization wild-type and nucleostemin (Tsai and McKay, 2002). Intriguingly as mutant p53 proteins were detected in the nucleoplasm of well, the first cellular DNA-binding site of p53 to be unpermeabilized cells and appeared to be excluded from identified (RGC) is located within the ribosomal gene nucleoli (Figure 1b). Interestingly, after permeabiliza- cluster (Kern et al., 1991). Recently, it was reported that tion, nucleoplasmic staining was generally weaker in mutant p53 localizes to nucleoli in cells treated with a wild-type p53 cells, whereas in approximately 10–15% compound (PRIMA-1) that was reported to reactivate of cells expressing p53Q22/S23 and p53H175 almost exclusive mutant forms of p53 (Bykov et al., 2002a, b; Rokaeus nucleolar staining was observed (Figure 1c). By con- et al., 2006). trast, wild-type p53 was never observed in the nucleoli. Under non-stressed conditions, p53 was reported to Co-staining cells with anti-nucleolin antibody confirmed localize to the nucleolus in permeabilized Hep G2 cells the nucleolar localization of mutant p53. Our observa- (Rubbi and Milner, 2000). The nuclear and nucleolar tions suggest that some of the p53 in the nucleus is not association of p53 in such cells is RNA-dependent as tightly attached to nuclear components and can freely RNase A treatment of permeabilized cells abrogates diffuse outside the nucleus, whereas a subpopulation of detection of most of the anchored p53. In addition, p53 in some cells can be anchored by attaching to treatment of human fibroblasts with MG132, a protea- nuclear and nucleolar components as was reported some inhibitor, causes p53 to accumulate in the previously (Rubbi and Milner, 2000; Klibanov et al., nucleolus and nucleoplasm both in directly fixed cells 2001). and in permeabilized cells (Klibanov et al., 2001; Both mutant p53Q22/S23- and p53H175-expressing Pokrovskaja et al., 2001; Latonen et al., 2003). Although cells contain at least two-fold more p53 than those its functional significance is unknown, the nucleolar expressing wild-type p53 when normalized to cellular sequestration of p53 was reported to be one of the actin levels (Figure 1 and 2). We therefore tested mechanisms contributing to the reactivation of p53 in whether the level of p53 protein can determine HeLa cells after treatment with cisplatin (Horky et al., sequestration of the mutant p53 into the nucleolus 2001; Wesierska-Gadek et al., 2002). by varying the amount of tetracycline in the culture In the present study, we have established conditions medium of mutant p53-expressing cells (Chen for characterizing the association of endogenously et al., 1996). Indeed, when the level of mutant p53 was expressed or exogenously added p53 with nucleoli and lowered to that of fully expressed wild-type p53 neither have identified some of the requirements for this p53Q22/S23 nor p53H175 relocalized to the nucleolus process. (Figure 2). To determine whether endogenously ex- pressed p53 in other cell lines could relocalize to nucleoli after permeabilization, we examined HT-29 cells RESULTS and T98G cells that each express high levels of mutant forms of p53. Note that the levels of endogenous The level of p53 within permeabilized H1299 cells mutant p53 in those cells are similar to those of p53H175 determines nucleolar sequestration that are expressed inducibly in H1299 cell line To investigate the localization
Recommended publications
  • Nucleolin and Its Role in Ribosomal Biogenesis
    NUCLEOLIN: A NUCLEOLAR RNA-BINDING PROTEIN INVOLVED IN RIBOSOME BIOGENESIS Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Julia Fremerey aus Hamburg Düsseldorf, April 2016 2 Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Referent: Prof. Dr. A. Borkhardt Korreferent: Prof. Dr. H. Schwender Tag der mündlichen Prüfung: 20.07.2016 3 Die vorgelegte Arbeit wurde von Juli 2012 bis März 2016 in der Klinik für Kinder- Onkologie, -Hämatologie und Klinische Immunologie des Universitätsklinikums Düsseldorf unter Anleitung von Prof. Dr. A. Borkhardt und in Kooperation mit dem ‚Laboratory of RNA Molecular Biology‘ an der Rockefeller Universität unter Anleitung von Prof. Dr. T. Tuschl angefertigt. 4 Dedicated to my family TABLE OF CONTENTS 5 TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................... 5 LIST OF FIGURES ......................................................................................................10 LIST OF TABLES .......................................................................................................12 ABBREVIATION .........................................................................................................13 ABSTRACT ................................................................................................................19 ZUSAMMENFASSUNG
    [Show full text]
  • Cancer Stem Cells and Nucleolin As Drivers of Carcinogenesis
    pharmaceuticals Review Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis Laura Sofia Carvalho 1,Nélio Gonçalves 1 , Nuno André Fonseca 1,2 and João Nuno Moreira 1,3,* 1 CNC—Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine (Polo 1), University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal; laurasofi[email protected] (L.S.C.); [email protected] (N.G.); [email protected] (N.A.F.) 2 TREAT U, SA—Parque Industrial de Taveiro, Lote 44, 3045-508 Coimbra, Portugal 3 UC—University of Coimbra, CIBB, Faculty of Pharmacy (FFUC), Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal * Correspondence: [email protected]; Tel.: +351-239-820-190 Abstract: Cancer, one of the most mortal diseases worldwide, is characterized by the gain of specific features and cellular heterogeneity. Clonal evolution is an established theory to explain heterogeneity, but the discovery of cancer stem cells expanded the concept to include the hierarchical growth and plasticity of cancer cells. The activation of epithelial-to-mesenchymal transition and its molecular players are widely correlated with the presence of cancer stem cells in tumors. Moreover, the acquisition of certain oncological features may be partially attributed to alterations in the levels, location or function of nucleolin, a multifunctional protein involved in several cellular processes. This review aims at integrating the established hallmarks of cancer with the plasticity of cancer cells as an emerging hallmark; responsible for tumor heterogeneity; therapy resistance and relapse. The discussion will contextualize the involvement of nucleolin in the establishment of cancer hallmarks and its application as a marker protein for targeted anticancer therapies Keywords: tumor heterogeneity; drug resistance; cancer stem cells; nucleolin; targeted therapies; epithelial-to-mesenchymal transition Citation: Carvalho, L.S.; Gonçalves, N.; Fonseca, N.A.; Moreira, J.N.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. Phosphoryl I-Area II-Area II-Debunker III-Area Gene Symbol Protein Name Phosphorylated Peptide I-R2 I-Debunker score II-R2 III-R2 ation Site Ratio Ratio score Ratio 92154 ABBA-1 Actin-bundling protein with BAIAP2 homologyK.TPTVPDS*PGYMGPTR.A S601 1.76 0.95 0.999958250 1.18 0.98 0.999971836 0.98 0.98 92154 ABBA-1 Actin-bundling protein with BAIAP2 homologyR.AGS*EECVFYTDETASPLAPDLAK.A S612 1.40 0.99 0.999977464 1.03 0.99 0.999986373 1.00 0.99 92154 ABBA-1 Actin-bundling protein with BAIAP2 homologyK.GGGAPWPGGAQTYS*PSSTCR.Y S300 0.49 0.98 0.999985406 0.97 0.99 0.999983906 2.03 0.97 23 ABCF1 ATP-binding cassette sub-family F memberK.QQPPEPEWIGDGESTS*PSDK.V 1 S22 1.09 0.98 0.872361494 0.81 1.00 0.847115585 0.97 0.97 27 ABL2 Isoform IA of Tyrosine-protein kinase ABL2K.VPVLIS*PTLK.H S936 0.76 0.98 0.999991559 1.06 0.99 0.999989547 0.99 0.96 3983 ABLIM1 Actin binding LIM protein 1 R.TLS*PTPSAEGYQDVR.D S433 1.27 0.99 0.999994010 1.16 0.98 0.999989861 1.11 0.99 31 ACACA acetyl-Coenzyme A carboxylase alpha isoformR.FIIGSVSEDNS*EDEISNLVK.L 1 S29 1.23 0.99 0.999992898 0.72 0.99 0.999992499 0.83 0.99 65057 ACD Adrenocortical dysplasia protein homologR.TPS*SPLQSCTPSLSPR.S S424 1.51 0.90 0.999936226 0.82 0.88 0.997623142 0.46 0.93 22985 ACIN1 Apoptotic chromatin condensation inducerK.ASLVALPEQTASEEET*PPPLLTK.E in the nucleus T414 0.90 0.92 0.922696554 0.91 0.92 0.993049132 0.95 0.99 22985 ACIN1 Apoptotic chromatin condensation inducerK.ASLVALPEQTAS*EEETPPPLLTK.E in the nucleus S410 1.02 0.99 0.997470008 0.80 0.99 0.999702808 0.96
    [Show full text]
  • The Role of Nucleolin in B-Cell Lymphomas and Fas-Mediated Apoptotic Signaling
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2013 The Role of Nucleolin in B-cell Lymphomas and Fas-Mediated Apoptotic Signaling Jillian F. Wise Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Cancer Biology Commons, and the Medicine and Health Sciences Commons Recommended Citation Wise, Jillian F., "The Role of Nucleolin in B-cell Lymphomas and Fas-Mediated Apoptotic Signaling" (2013). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 339. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/339 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. The Role of Nucleolin in B-cell Lymphomas and Fas-Mediated Apoptotic Signaling by Jillian F Wise, BS Approved: ___________________________________________________ Felipe
    [Show full text]
  • The Role of Nucleolin Phosphorylation by CK2 in Regulating Cellular Fate Under Normal and Stress Conditions
    City University of New York (CUNY) CUNY Academic Works All Dissertations, Theses, and Capstone Projects Dissertations, Theses, and Capstone Projects 9-2017 The Role of Nucleolin Phosphorylation by CK2 in Regulating Cellular Fate Under Normal and Stress Conditions Shu Xiao The Graduate Center, City University of New York How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/gc_etds/2412 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] THE ROLE OF NUCLEOLIN PHOSPHORYLATION BY CK2 IN REGULATING CELLULAR FATE UNDER NORMAL AND STRESS CONDITIONS by Shu Xiao A dissertation submitted to the Graduate Faculty in Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy, The City University of New York 2017 © 2017 Shu Xiao All Rights Reserved ii The role of nucleolin phosphorylation by CK2 in regulating cellular fate under normal and stress conditions by Shu Xiao This manuscript has been read and accepted for the Graduate Faculty in Biology in satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. Anjana Saxena Date Chair of Examining Committee Cathy Savage-Dunn Date Executive Officer Supervising Committee: Frida Kleiman Xinyin Jiang Jimmie Fata James Borowiec THE CITY UNIVERSITY OF NEW YORK iii ABSTRACT The role of nucleolin phosphorylation by CK2 in regulating cellular fate under normal and stress conditions by Shu Xiao Advisor: Dr. Anjana Saxena Nucleolin (NCL or C23) is an abundant genotoxic stress-responsive RNA binding phosphoprotein.
    [Show full text]
  • Interplay of RNA-Binding Proteins and Micrornas in Neurodegenerative Diseases
    International Journal of Molecular Sciences Review Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases Chisato Kinoshita 1,* , Noriko Kubota 1,2 and Koji Aoyama 1,* 1 Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan; [email protected] 2 Teikyo University Support Center for Women Physicians and Researchers, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan * Correspondence: [email protected] (C.K.); [email protected] (K.A.); Tel.: +81-3-3964-3794 (C.K.); +81-3-3964-3793 (K.A.) Abstract: The number of patients with neurodegenerative diseases (NDs) is increasing, along with the growing number of older adults. This escalation threatens to create a medical and social crisis. NDs include a large spectrum of heterogeneous and multifactorial pathologies, such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and multiple system atrophy, and the formation of inclusion bodies resulting from protein misfolding and aggregation is a hallmark of these disorders. The proteinaceous components of the pathological inclusions include several RNA-binding proteins (RBPs), which play important roles in splicing, stability, transcription and translation. In addition, RBPs were shown to play a critical role in regulating miRNA biogenesis and metabolism. The dysfunction of both RBPs and miRNAs is Citation: Kinoshita, C.; Kubota, N.; often observed in several NDs. Thus, the data about the interplay among RBPs and miRNAs and Aoyama, K. Interplay of RNA-Binding Proteins and their cooperation in brain functions would be important to know for better understanding NDs and microRNAs in Neurodegenerative the development of effective therapeutics.
    [Show full text]
  • Live-Cell Imaging Rnai Screen Identifies PP2A–B55α and Importin-Β1 As Key Mitotic Exit Regulators in Human Cells
    LETTERS Live-cell imaging RNAi screen identifies PP2A–B55α and importin-β1 as key mitotic exit regulators in human cells Michael H. A. Schmitz1,2,3, Michael Held1,2, Veerle Janssens4, James R. A. Hutchins5, Otto Hudecz6, Elitsa Ivanova4, Jozef Goris4, Laura Trinkle-Mulcahy7, Angus I. Lamond8, Ina Poser9, Anthony A. Hyman9, Karl Mechtler5,6, Jan-Michael Peters5 and Daniel W. Gerlich1,2,10 When vertebrate cells exit mitosis various cellular structures can contribute to Cdk1 substrate dephosphorylation during vertebrate are re-organized to build functional interphase cells1. This mitotic exit, whereas Ca2+-triggered mitotic exit in cytostatic-factor- depends on Cdk1 (cyclin dependent kinase 1) inactivation arrested egg extracts depends on calcineurin12,13. Early genetic studies in and subsequent dephosphorylation of its substrates2–4. Drosophila melanogaster 14,15 and Aspergillus nidulans16 reported defects Members of the protein phosphatase 1 and 2A (PP1 and in late mitosis of PP1 and PP2A mutants. However, the assays used in PP2A) families can dephosphorylate Cdk1 substrates in these studies were not specific for mitotic exit because they scored pro- biochemical extracts during mitotic exit5,6, but how this relates metaphase arrest or anaphase chromosome bridges, which can result to postmitotic reassembly of interphase structures in intact from defects in early mitosis. cells is not known. Here, we use a live-cell imaging assay and Intracellular targeting of Ser/Thr phosphatase complexes to specific RNAi knockdown to screen a genome-wide library of protein substrates is mediated by a diverse range of regulatory and targeting phosphatases for mitotic exit functions in human cells. We subunits that associate with a small group of catalytic subunits3,4,17.
    [Show full text]
  • Integrative Framework for Identification of Key Cell Identity Genes Uncovers
    Integrative framework for identification of key cell PNAS PLUS identity genes uncovers determinants of ES cell identity and homeostasis Senthilkumar Cinghua,1, Sailu Yellaboinaa,b,c,1, Johannes M. Freudenberga,b, Swati Ghosha, Xiaofeng Zhengd, Andrew J. Oldfielda, Brad L. Lackfordd, Dmitri V. Zaykinb, Guang Hud,2, and Raja Jothia,b,2 aSystems Biology Section and dStem Cell Biology Section, Laboratory of Molecular Carcinogenesis, and bBiostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709; and cCR Rao Advanced Institute of Mathematics, Statistics, and Computer Science, Hyderabad, Andhra Pradesh 500 046, India Edited by Norbert Perrimon, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, and approved March 17, 2014 (received for review October 2, 2013) Identification of genes associated with specific biological pheno- (mESCs) for genes essential for the maintenance of ESC identity types is a fundamental step toward understanding the molecular resulted in only ∼8% overlap (8, 9), although many of the unique basis underlying development and pathogenesis. Although RNAi- hits in each screen were known or later validated to be real. The based high-throughput screens are routinely used for this task, lack of concordance suggest that these screens have not reached false discovery and sensitivity remain a challenge. Here we describe saturation (14) and that additional genes of importance remain a computational framework for systematic integration of published to be discovered. gene expression data to identify genes defining a phenotype of Motivated by the need for an alternative approach for iden- interest. We applied our approach to rank-order all genes based on tification of key cell identity genes, we developed a computa- their likelihood of determining ES cell (ESC) identity.
    [Show full text]
  • Telomerase Reverse Transcriptase Promotes Cancer Cell Proliferation by Augmenting Trna Expression
    The Journal of Clinical Investigation RESEARCH ARTICLE Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression Ekta Khattar,1 Pavanish Kumar,2 Chia Yi Liu,1 Semih Can Akıncılar,1 Anandhkumar Raju,1 Manikandan Lakshmanan,1 Julien Jean Pierre Maury,3 Yu Qiang,4 Shang Li,5 Ern Yu Tan,6 Kam M. Hui,5,7,8,9 Ming Shi,10 Yuin Han Loh,3 and Vinay Tergaonkar1,11 1Division of Cancer Genetics and Therapeutics, Laboratory of NFκB Signaling, Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research),Singapore. 2Singapore Immunology Network, A*STAR, Singapore. 3Epigenetics and Cell Fates Laboratory, IMCB, A*STAR, Singapore. 4Genome Institute of Singapore, A*STAR, Singapore. 5Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore. 6Department of General Surgery, Tan Tock Seng Hospital, Singapore. 7National Cancer Centre, Singapore. 8Institute of Molecular and Cell Biology, A*STAR, Singapore. 9Department of Biochemistry, Yong Loo Lin School of Medicine, NUS, Singapore. 10Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. 11Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia. Transcriptional reactivation of telomerase reverse transcriptase (TERT) reconstitutes telomerase activity in the majority of human cancers. Here, we found that ectopic TERT expression increases cell proliferation, while acute reductions in TERT levels lead to a dramatic loss of proliferation without any change in telomere length, suggesting that the effects of TERT could be telomere independent. We observed that TERT determines the growth rate of cancer cells by directly regulating global protein synthesis independently of its catalytic activity.
    [Show full text]
  • Altered Nucleophosmin Transport in Acute Myeloid Leukaemia with Mutated NPM1: Molecular Basis and Clinical Implications
    Leukemia (2009) 23, 1731–1743 & 2009 Macmillan Publishers Limited All rights reserved 0887-6924/09 $32.00 www.nature.com/leu REVIEW Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications B Falini1, N Bolli1,5, A Liso2, MP Martelli1, R Mannucci3, S Pileri4 and I Nicoletti3 1The Institute of Haematology, University of Perugia, IBiT Foundation, Fondazione IRCCS Biotecnologie nel Trapianto, Perugia, Italy; 2Institute of Haematology, University of Foggia, Foggia, Italy; 3Institute of Internal Medicine, University of Perugia, Perugia, Italy and 4Unit of Haematopathology, Policlinico S. Orsola, University of Bologna, Bologna, Italy Nucleophosmin (NPM1) is a highly conserved nucleo-cytoplas- n. NM_001037738) with a distinct C-terminus; it accounts for mic shuttling protein that shows a restricted nucleolar localiza- minimal nucleophosmin content in tissues. NPM1 (B23.1) and tion. Mutations of NPM1 gene leading to aberrant cytoplasmic NPM1.2 (B23.2) have different subcellular distribution patterns:5 dislocation of nucleophosmin (NPMc þ ) occurs in about one 6,7 third of acute myeloid leukaemia (AML) patients that exhibit NPM1 protein is localized only in the nucleolus and NPM1.2 8 distinctive biological and clinical features. We discuss the mainly in the nucleoplasm. A third variant (accession number latest advances in the molecular basis of nucleophosmin traffic NM_199185) lacks an alternate in-frame exon compared with under physiological conditions, describe the molecular ab- variant 1, resulting in a shorter protein whose functions and normalities underlying altered transport of nucleophosmin in expression pattern are unknown. NPM1-mutated AML and present evidences supporting the view that cytoplasmic nucleophosmin is a critical event for leukae- Experiments on NPM1/B23 migration in interspecies (chick- mogenesis.
    [Show full text]
  • Modulation of Gene Expression by RNA Binding Proteins: Mrna Stability and Translation
    Chapter 5 Modulation of Gene Expression by RNA Binding Proteins: mRNA Stability and Translation Kotb Abdelmohsen Additional information is available at the end of the chapter http://dx.doi.org/10.5772/48485 1. Introduction Regulation of gene expression is an essential process through which mammalian cells counter the changes in their microenvironment. These changes drive cells to respond to different stimuli that trigger cellular re-programming towards proliferation, differentiation, development, apoptosis, senescence, carcinogenesis, etc. Once mRNAs are transcribed they are subjected to posttranscriptional events that regulate mRNA metabolism including stability and translation. These two processes normally dictate the protein levels encoded by mRNA. RNA-binding proteins (RPBs) that bind mature mRNA sequences normally have an important regulatory effect on the mRNA. RBPs are also named mRNA turnover and translation regulator RBPs (TTR-RBPs) since they are capable of regulating both mRNA stability and translation. This family includes numerous members such as Hu proteins [HuA (HuR), HuB, HuC, and HuD] known to bind AU-rich sequences in the 3’ untranslated region (3’UTR) to enhance mRNA translation or to increase its stability [1, 2]. Other RBPs such as T-cell intracellular antigen 1 (TIA-1), TIA-1- related (TIAR), tristetraprolin (TTP), fragile X mental retardation protein (FMRP), polypyrimidine tract-binding protein (PTB), CUG triple repeats RNA-binding protein (CUGBP), nucleolin, and heterogeneous nuclear ribonucleoproteins (hnRNP) A1, A2, and C1/C2 have been shown to influence mRNA stability or translation through interaction with the 3’UTR, CR or the 5’UTR [3-9]. Hu proteins are among the RBPs that are well characterized.
    [Show full text]
  • BMC Bioinformatics Biomed Central
    BMC Bioinformatics BioMed Central Research article Open Access The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations Xue Lin1, Bahman Afsari2, Luigi Marchionni3, Leslie Cope3, Giovanni Parmigiani3,4, Daniel Naiman*1 and Donald Geman1,5 Address: 1Department of Applied Mathematics and Statistics, The Johns Hopkins University, Baltimore, Maryland, USA, 2Department of Electrical and Computer Engineering, The Johns Hopkins University, Baltimore, Maryland, USA, 3Department of Oncology, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA, 4Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA and 5Institute for Computational Medicine, The Johns Hopkins University, Baltimore, Maryland, USA Email: Xue Lin - [email protected]; Bahman Afsari - [email protected]; Luigi Marchionni - [email protected]; Leslie Cope - [email protected]; Giovanni Parmigiani - [email protected]; Daniel Naiman* - [email protected]; Donald Geman - [email protected] * Corresponding author Published: 20 August 2009 Received: 12 May 2009 Accepted: 20 August 2009 BMC Bioinformatics 2009, 10:256 doi:10.1186/1471-2105-10-256 This article is available from: http://www.biomedcentral.com/1471-2105/10/256 © 2009 Lin et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: A major challenge in computational biology is to extract knowledge about the genetic nature of disease from high-throughput data. However, an important obstacle to both biological understanding and clinical applications is the "black box" nature of the decision rules provided by most machine learning approaches, which usually involve many genes combined in a highly complex fashion.
    [Show full text]